DETRUSITOL tolterodine tartrate 2mg tablet blister pack ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

detrusitol tolterodine tartrate 2mg tablet blister pack

viatris pty ltd - tolterodine tartrate, quantity: 2 mg - tablet, film coated - excipient ingredients: stearic acid; calcium hydrogen phosphate dihydrate; microcrystalline cellulose; colloidal anhydrous silica; sodium starch glycollate; titanium dioxide; hypromellose; magnesium stearate - detrusitol is indicated for the treatment of patients with overactive bladder with symptoms of urinary frequency, urgency or incontinence or any combination of these symptoms.

Detrusitol 1mg film-coated tablets माल्टा - अंग्रेज़ी - Medicines Authority

detrusitol 1mg film-coated tablets

pfizer hellas s.a. - tolterodine l, tartrate - film-coated tablet - tolterodine l-tartrate 1 milligram(s) - urologicals

Detrusitol 1mg film-coated tablets माल्टा - अंग्रेज़ी - Medicines Authority

detrusitol 1mg film-coated tablets

viatris hellas ltd 253-255, mesogion avenue, 154 51 neo psychiko, athens,, greece - tolterodine l, tartrate - film-coated tablet - tolterodine l-tartrate 1 mg - urologicals

Detrusitol 2 mg film-coated tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

detrusitol 2 mg film-coated tablets

imbat limited - tolterodine tartare - film-coated tablet - 2 milligram(s) - drugs for urinary frequency and incontinence

Detrusitol 1 mg film-coated tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

detrusitol 1 mg film-coated tablets

pfizer healthcare ireland - tolterodine tartrate - film-coated tablet - 1 milligram(s) - drugs for urinary frequency and incontinence; tolterodine

DETRUSITOL tolterodine  tartrate 1mg tablet blister pack ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

detrusitol tolterodine tartrate 1mg tablet blister pack

viatris pty ltd - tolterodine tartrate, quantity: 1 mg - tablet, film coated - excipient ingredients: stearic acid; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; colloidal anhydrous silica; magnesium stearate; hypromellose; sodium starch glycollate; titanium dioxide - detrusitol is indicated for the treatment of patients with overactive bladder with symptoms of urinary frequency, urgency or incontinence or any combination of these symptoms.

Detrusitol 1 mg film-coated tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

detrusitol 1 mg film-coated tablets

upjohn eesv - tolterodine tartrate - film-coated tablet - 1 milligram(s) - drugs for urinary frequency and incontinence; tolterodine

Detrusitol 2 mg नामीबिया - अंग्रेज़ी - Namibia Medicines Regulatory Council

detrusitol 2 mg

pfizer laboratories (pty) ltd - tolterodine l-tartrate - tablets - tolterodine l-tartrate tablets 2.0mg